Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Colombel

Showing results (41-50 of 368) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|July 4, 1987
Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effectsJ F Colombel, A Cortot, C Neut, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2016
Editorial: serologic microbial associated markers to predict Crohn's disease behaviour - authors' replyJ-F Colombel, M S Riddle, J A Murray
The American Review of Respiratory Disease|August 1, 1991
Human alveolar macrophage antibacterial activity in the alcoholic lungB Wallaert, C Aerts, J F Colombel, et al.
Gut|April 17, 2001
Antibiotics in Crohn's diseaseJ F Colombel, A Cortot, H J van Kruiningen
Inflammatory Bowel Diseases|June 1, 2001
The importance of familial clusterings in Crohn's diseaseH J Van Kruiningen, A Cortot, J F Colombel
Gastroenterologie Clinique Et Biologique|February 7, 2001
[Cyclo 3 Fort-induced lymphocytic colitis associated with ileal villous atrophy]S Dharancy, V Dapvril, F Dupont-Evrard, et al.
Gut|June 15, 2004
Dysbiosis as a prerequisite for IBDC P Tamboli, C Neut, P Desreumaux, et al.
Gut|May 16, 2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsJ Satsangi, M S Silverberg, S Vermeire, et al.
Endoscopy|September 29, 2005
ICCE consensus for inflammatory bowel diseaseA Kornbluth, J F Colombel, J A Leighton, et al.
Gastroenterology|January 1, 1997
Do pANCA define a clinical subgroup in patients with Crohn's disease?N Jamar-Leclerc, D Reumaux, P Duthilleul, et al.
Pageof 37

Showing results (41-50 of 368) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|July 4, 1987
Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effectsJ F Colombel, A Cortot, C Neut, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2016
Editorial: serologic microbial associated markers to predict Crohn's disease behaviour - authors' replyJ-F Colombel, M S Riddle, J A Murray
The American Review of Respiratory Disease|August 1, 1991
Human alveolar macrophage antibacterial activity in the alcoholic lungB Wallaert, C Aerts, J F Colombel, et al.
Gut|April 17, 2001
Antibiotics in Crohn's diseaseJ F Colombel, A Cortot, H J van Kruiningen
Inflammatory Bowel Diseases|June 1, 2001
The importance of familial clusterings in Crohn's diseaseH J Van Kruiningen, A Cortot, J F Colombel
Gastroenterologie Clinique Et Biologique|February 7, 2001
[Cyclo 3 Fort-induced lymphocytic colitis associated with ileal villous atrophy]S Dharancy, V Dapvril, F Dupont-Evrard, et al.
Gut|June 15, 2004
Dysbiosis as a prerequisite for IBDC P Tamboli, C Neut, P Desreumaux, et al.
Gut|May 16, 2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsJ Satsangi, M S Silverberg, S Vermeire, et al.
Endoscopy|September 29, 2005
ICCE consensus for inflammatory bowel diseaseA Kornbluth, J F Colombel, J A Leighton, et al.
Gastroenterology|January 1, 1997
Do pANCA define a clinical subgroup in patients with Crohn's disease?N Jamar-Leclerc, D Reumaux, P Duthilleul, et al.
Pageof 37